{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:49:03Z","timestamp":1772902143791,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"S4","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12918-016-0364-2","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T11:37:42Z","timestamp":1482493062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The extraction of drug-disease correlations based on module distance in incomplete human interactome"],"prefix":"10.1186","volume":"10","author":[{"given":"Liang","family":"Yu","sequence":"first","affiliation":[]},{"given":"Bingbo","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xiaoke","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Lin","family":"Gao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"issue":"5","key":"364_CR1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mcp.2001.115132","volume":"69","author":"JA Dimasi","year":"2001","unstructured":"Dimasi JA. New drug development in the United States from 1963 to 1999. Clin Pharmacol Ther. 2001;69(5):286\u201396.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"364_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1377\/hlthaff.25.2.420","volume":"25","author":"CP Adams","year":"2006","unstructured":"Adams CP, Brantner VV. Estimating the cost of new drug development: is it really $802 million? Health Aff (Millwood). 2006;25(2):420\u20138.","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"364_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03256811","volume":"24","author":"SH Sleigh","year":"2010","unstructured":"Sleigh SH, Barton CL. Repurposing Strategies for Therapeutics. Pharm Med. 2010;24(3):151\u20139.","journal-title":"Pharm Med"},{"issue":"5","key":"364_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2013.03.004","volume":"34","author":"N Novac","year":"2013","unstructured":"Novac N. Challenges and opportunities of drug repositioning. Trends Pharmacol Sci. 2013;34(5):267\u201372.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"364_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","volume":"78","author":"SL Walker","year":"2007","unstructured":"Walker SL, Waters MF, Lockwood DN. The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev. 2007;78(3):197\u2013215.","journal-title":"Lepr Rev"},{"issue":"Suppl 1","key":"364_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12859-015-0845-0","volume":"17","author":"CH Huang","year":"2016","unstructured":"Huang CH, Chang PM, Hsu CW, Huang CY, Ng KL. Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory. BMC Bioinformatics. 2016;17 Suppl 1:2.","journal-title":"BMC Bioinformatics"},{"key":"364_CR7","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1038\/srep11970","volume":"5","author":"C Zheng","year":"2015","unstructured":"Zheng C, Guo Z, Huang C, Wu Z, Li Y, Chen X, Fu Y, Ru J, Ali Shar P, Wang Y, Wang Y. Large-scale Direct Targeting for Drug Repositioning and Discovery. Sci Rep. 2015;5:11970.","journal-title":"Sci Rep"},{"issue":"5","key":"364_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cpt.82","volume":"97","author":"H Wang","year":"2015","unstructured":"Wang H, Gu Q, Wei J, Cao Z, Liu Q. Mining Drug-disease Relationships As a Complement to Medical Genetics-based Drug Repositioning: Where A Rec-ommendation System Meets Genome-wide Association Studies. Clin Pharmacol Ther. 2015;97(5):451\u20134.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"364_CR9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/c3mb25309k","volume":"9","author":"F Cheng","year":"2013","unstructured":"Cheng F, Li W, Zhou Y, Li J, Shen J, Lee PW, Tang Y. Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs). Mol Biosyst. 2013;9(6):1316\u201325.","journal-title":"Mol Biosyst"},{"issue":"7261","key":"364_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature08454","volume":"461","author":"EE Schadt","year":"2009","unstructured":"Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009;461(7261):218\u201323.","journal-title":"Nature"},{"issue":"8","key":"364_CR11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ng.2355","volume":"44","author":"A Califano","year":"2012","unstructured":"Califano A, Butte AJ, Friend S, Ideker T, Schadt E. Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat Genet. 2012;44(8):841\u20137.","journal-title":"Nat Genet"},{"issue":"11","key":"364_CR12","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.febslet.2009.03.001","volume":"583","author":"A Zanzoni","year":"2009","unstructured":"Zanzoni A, Soler-L\u00f3pez M, Aloy P. A network medicine approach to human disease. FEBS Lett. 2009;583(11):1759\u201365.","journal-title":"FEBS Lett"},{"issue":"1","key":"364_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"AL Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si AL, Gulbahce N, Loscalzo J. Network medicine: A network-based approach to human disease. Nat Rev Genet. 2011;12(1):56\u201368.","journal-title":"Nat Rev Genet"},{"issue":"21","key":"364_CR14","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1073\/pnas.0701361104","volume":"104","author":"KI Goh","year":"2007","unstructured":"Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barab\u00e1si AL. The human disease network. Proc Natl Acad Sci U S A. 2007;104(21):8685\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"364_CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/msb.2010.36","volume":"6","author":"K Lage","year":"2010","unstructured":"Lage K, M\u00f8llg\u00e5rd K, Greenway S, Wakimoto H, Gorham JM, Workman CT, Bendsen E, Hansen NT, Rigina O, Roque FS, Wiese C, Christoffels VM, Roberts AE, Smoot LB, Pu WT, Donahoe PK, Tommerup N, Brunak S, Seidman CE, Seidman JG, Larsen LA. Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol Syst Biol. 2010;6:381.","journal-title":"Mol Syst Biol"},{"key":"364_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/msb4100180","volume":"3","author":"HY Chuang","year":"2007","unstructured":"Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007;3:140.","journal-title":"Mol Syst Biol"},{"issue":"5","key":"364_CR17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2014.10.050","volume":"159","author":"T Rolland","year":"2014","unstructured":"Rolland T, et al. A proteome-scale map of the human interactome network. Cell. 2014;159(5):1212\u201326.","journal-title":"Cell"},{"key":"364_CR18","doi-asserted-by":"crossref","unstructured":"Luo H, Wang J, Li M, Luo J, Peng X, Wu FX, Pan Y. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm. Bioinformatics. 2016;32(17):2664-71.","DOI":"10.1093\/bioinformatics\/btw228"},{"issue":"Suppl 2","key":"364_CR19","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","volume":"8","author":"L Yu","year":"2015","unstructured":"Yu L, Huang J, Ma Z, Zhang J, Zou Y, Gao L. Inferring drug-disease associations based on known protein complexes. BMC Med Genomics. 2015;8 Suppl 2:S2.","journal-title":"BMC Med Genomics"},{"key":"364_CR20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7:496.","journal-title":"Mol Syst Biol"},{"issue":"6","key":"364_CR21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.sbi.2013.07.005","volume":"23","author":"R Mosca","year":"2013","unstructured":"Mosca R, Pons T, C\u00e9ol A, Valencia A, Aloy P. Towards a detailed atlas of protein-protein interactions. Curr Opin Struct Biol. 2013;23(6):929\u201340.","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"364_CR22","doi-asserted-by":"crossref","first-page":"i243","DOI":"10.1093\/bioinformatics\/btw245","volume":"32","author":"S Mohammadi","year":"2016","unstructured":"Mohammadi S, Grama A. A convex optimization approach for identification of human tissue-specific interactomes. Bioinformatics. 2016;32(12):i243\u201352.","journal-title":"Bioinformatics"},{"issue":"11","key":"364_CR23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/gb-2006-7-11-120","volume":"7","author":"GT Hart","year":"2006","unstructured":"Hart GT, Ramani AK, Marcotte EM. How complete are current yeast and human protein-interaction networks? Genome Biol. 2006;7(11):120.","journal-title":"Genome Biol"},{"issue":"1","key":"364_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nmeth.1280","volume":"6","author":"K Venkatesan","year":"2009","unstructured":"Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, Rau K, Boone C, Braun P, Cusick ME, Roth FP, Hill DE, Tavernier J, Wanker EE, Barab\u00e1si AL, Vidal M. An empirical framework for binary interactome mapping. Nat Methods. 2009;6(1):83\u201390.","journal-title":"Nat Methods"},{"issue":"19","key":"364_CR25","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1073\/pnas.0708078105","volume":"105","author":"MP Stumpf","year":"2008","unstructured":"Stumpf MP, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C. Estimating the size of the human interactome. Proc Natl Acad Sci U S A. 2008;105(19):6959\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"364_CR26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.sbi.2011.03.013","volume":"21","author":"MN Wass","year":"2011","unstructured":"Wass MN, David A, Sternberg MJ. Challenges for the prediction of macromolecular interactions. Curr Opin Struct Biol. 2011;21(3):382\u201390.","journal-title":"Curr Opin Struct Biol"},{"issue":"6224","key":"364_CR27","doi-asserted-by":"crossref","first-page":"1257601","DOI":"10.1126\/science.1257601","volume":"347","author":"J Menche","year":"2015","unstructured":"Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barab\u00e1si AL. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347(6224):1257601.","journal-title":"Science"},{"key":"364_CR28","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","volume":"7","author":"G Emre","year":"2016","unstructured":"Emre G, J\u00f6rg M, Marc V, Bar\u00e1basi AL. Network-based in silico drug efficacy screening. Nat Commun. 2016;7:10331.","journal-title":"Nat Commun"},{"issue":"Database issue","key":"364_CR29","doi-asserted-by":"crossref","first-page":"D914","DOI":"10.1093\/nar\/gku935","volume":"43","author":"AP Davis","year":"2015","unstructured":"Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, Wiegers TC, Mattingly CJ. The Comparative Toxicogenomics Database's 10th year anniversary: update 2015. Nucleic Acids Res. 2015;43(Database issue):D914\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"364_CR30","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"364_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"364_CR32","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014;42(Database issue):D1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"364_CR33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"1","key":"364_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"364_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Statist Soc B"},{"key":"364_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1177391X0800200001","volume":"2","author":"CJ Landmark","year":"2008","unstructured":"Landmark CJ, Johannessen SI. Modifications of antiepileptic drugs for improved tolerability and efficacy. Perspect Medicin Chem. 2008;2:21\u201339.","journal-title":"Perspect Medicin Chem"},{"issue":"1","key":"364_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1358\/dot.2010.46.1.1424766","volume":"46","author":"G Merlino","year":"2010","unstructured":"Merlino G, Serafini A, Lorenzut S, Sommaro M, Gigli GL, Valente M. Gabapentin enacarbil in restless legs syndrome. Drugs Today (Barc). 2010;46(1):3\u201311.","journal-title":"Drugs Today (Barc)"},{"key":"364_CR38","unstructured":"Jeffrey Susan. FDA Approves Gabapentin Enacarbil for Postherpetic Neuralgia. 2012."},{"issue":"4","key":"364_CR39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"EK Kim","year":"2010","unstructured":"Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802(4):396\u2013405.","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"364_CR40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","volume":"299","author":"J Keiser","year":"2008","unstructured":"Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;299(16):1937\u201348.","journal-title":"JAMA"},{"issue":"1","key":"364_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cbr.2010.0902","volume":"26","author":"RO Dillman","year":"2011","unstructured":"Dillman RO. Cancer immunotherapy. Cancer Biother Radiopharm. 2011;26(1):1\u201364.","journal-title":"Cancer Biother Radiopharm"},{"issue":"6","key":"364_CR42","first-page":"617","volume":"35","author":"P Balaram","year":"1988","unstructured":"Balaram P, Remani P, Padmanabhan TK, Vasudevan DM. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up. Neoplasma. 1988;35(6):617\u201325.","journal-title":"Neoplasma"},{"issue":"2","key":"364_CR43","first-page":"235","volume":"35","author":"P Balaram","year":"1988","unstructured":"Balaram P, Padmanabhan TK, Vasudevan DM. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations. Neoplasma. 1988;35(2):235\u201342.","journal-title":"Neoplasma"},{"issue":"5","key":"364_CR44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/JCO.1991.9.5.729","volume":"9","author":"IC Quirt","year":"1991","unstructured":"Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, Paterson AH, Prentice R, Silver HK, Willan AR, et al. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1991;9(5):729\u201335.","journal-title":"J Clin Oncol"},{"issue":"1","key":"364_CR45","first-page":"81","volume":"29","author":"TA Pulay","year":"1982","unstructured":"Pulay TA, Cs\u00f6m\u00f6r S. Effect of levamisole treatment on immunological parameters and the early course of cervical cancer. Neoplasma. 1982;29(1):81\u20136.","journal-title":"Neoplasma"},{"key":"364_CR46","unstructured":"\"You Can Control Your Cholesterol: A Guide to Low-Cholesterol Living\". Krames Communications. 1989."},{"issue":"37","key":"364_CR47","doi-asserted-by":"crossref","first-page":"13811","DOI":"10.1073\/pnas.0807500105","volume":"105","author":"S Teres","year":"2008","unstructured":"Teres S, Barcelo-Coblijn G, Benet M, Alvarez R, Bressani R, Halver JE, Escriba PV. Oleic acid content is responsible for the reduction in blood pressure induced by olive oil. Proc Natl Acad Sci. 2008;105(37):13811\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"364_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.plefa.2010.06.003","volume":"83","author":"J Shannon","year":"2010","unstructured":"Shannon J, O\u2019Malley J, Mori M, Garzotto M, Palma AJ, King IB. Erythrocyte fatty acids and prostate cancer risk: A comparison of methods. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):161\u20139.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"14","key":"364_CR49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/93.14.1088","volume":"93","author":"V Pala","year":"2001","unstructured":"Pala V, Krogh V, Muti P, Chajes V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F. Erythrocyte Membrane Fatty Acids and Subsequent Breast Cancer: A Prospective Italian Study. J Natl Cancer Inst. 2001;93(14):1088\u201395.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"364_CR50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ijc.2910580604","volume":"58","author":"JM Martin-Moreno","year":"1994","unstructured":"Martin-Moreno JM, Willett WC, Gorgojo L, Banegas JR, Rodriguez-Artalejo F, Fernandez-Rodriguez JC, Maisonneuve P, Boyle P. Dietary fat, olive oil intake and breast cancer risk. Int J Cancer. 1994;58(6):774\u201380.","journal-title":"Int J Cancer"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-016-0364-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:13:14Z","timestamp":1718968394000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-016-0364-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":50,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s12918-016-0364-2","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"111"}}